Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.49 |
| ▸ | MAOB | P27338 | 4/20 | 0.49 |
| ▸ | ACHE | P22303 | 3/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.39 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.39 |
| ▸ | TOP2A | P11388 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.36 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5021388 | 0.97 | MAOA (0.49) | MAOAMAOBACHEKDM4EATM | |
| SCHEMBL5021387 | 0.92 | MAOA (0.56) | MAOAMAOBACHEKDM4EATM | |
| SCHEMBL16356751 | 0.92 | MAOA (0.56) | MAOAMAOBACHEKDM4EATM | |
| SCHEMBL16356750 | 0.92 | MAOA (0.56) | MAOAMAOBACHEKDM4EATM | |
| SCHEMBL261895 | 0.92 | MAOA (0.56) | MAOAMAOBACHEKDM4EATM | |
| SCHEMBL804490 | 0.91 | KDM4E (0.43) | MAOAMAOBACHEKDM4EATM | |
| SCHEMBL966613 | 0.88 | MAOA (0.47) | MAOAMAOBACHEKDM4EATM | |
| SCHEMBL1963751 | 0.88 | MAOA (0.47) | MAOAMAOBACHEKDM4EATM | |
| SCHEMBL21100432 | 0.87 | MAOA (0.51) | MAOAMAOBACHEKDM4EATM | |
| SCHEMBL966752 | 0.86 | MAOA (0.50) | MAOAMAOBACHEKDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2463287-B1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO LTD (JP) | 2015-03-18 | — | — | EP | disclosed |
| US-8927119-B2 | Compound having substituted anthracene ring structure and pyridoindole ring structure, and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2015-01-06 | — | — | US | disclosed |
| EP-2463287-A1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE AND ORGANIC ELECTROLUMINESCENCE DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2012-06-13 | — | — | EP | disclosed |
| US-20120126220-A1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120126220-A1 | COMPOUND HAVING SUBSTITUTED ANTHRACENE RING STRUCTURE AND PYRIDOINDOLE RING STRUCTURE, AND ORGANIC ELECTROLUMINESCENT DEVICE | SLCO2B1, PNPO, SLCO2A1 | MAOA 314/4885MAOB 226/4885ACHE 406/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.